RepliCel Closes Second Tranche of Strategic Investment Commitment
Press release content from Accesswire. The AP news staff was not involved in its creation. RepliCel Closes Second Tranche of Strategic Investment Commitment April 29, 2021 GMT MainPointe Pharmaceuticals Completes Largest Scheduled Share Purchases per Investment Agreement VANCOUVER, BC / ACCESSWIRE / April 29, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF) (TSXV:RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthoped...
United States British Columbia John Schutte Lee Buckler Replicel Life Sciences Inc Mainpointe Pharmaceuticals
Source: apnews.com